Reconstruction of cellular signal transduction networks using perturbation assays and linear programming

• Verfasst von: Knapp, Bettina [VerfasserIn]
• Verfasst von: Kaderali, Lars [VerfasserIn]
• Titel: Reconstruction of cellular signal transduction networks using perturbation assays and linear programming
• Verf.angabe: Bettina Knapp, Lars Kaderali
• E-Jahr: 2013
• Jahr: July 30, 2013
• Umfang: 13 S.
• Fussnoten: Gesehen am 07.06.2022
• Titel Quelle: Enthalten in: PLOS ONE
• Ort Quelle: San Francisco, California, US : PLOS, 2006
• Jahr Quelle: 2013
• Band/Heft Quelle: 8(2013), 7, Artikel-ID e69220, Seite 1-13
• ISSN Quelle: 1932-6203
• DOI: doi:10.1371/journal.pone.0069220
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Cyclins
• Sach-SW: Flow cytometry
• Sach-SW: Genetic networks
• Sach-SW: Protein interaction networks
• Sach-SW: Signal transduction
• Sach-SW: Signaling networks
• Sach-SW: Simulation and modeling
• Sach-SW: T cells
• K10plus-PPN: 1752013794

Abstract

Perturbation experiments for example using RNA interference (RNAi) offer an attractive way to elucidate gene function in a high throughput fashion. The placement of hit genes in their functional context and the inference of underlying networks from such data, however, are challenging tasks. One of the problems in network inference is the exponential number of possible network topologies for a given number of genes. Here, we introduce a novel mathematical approach to address this question. We formulate network inference as a linear optimization problem, which can be solved efficiently even for large-scale systems. We use simulated data to evaluate our approach, and show improved performance in particular on larger networks over state-of-the art methods. We achieve increased sensitivity and specificity, as well as a significant reduction in computing time. Furthermore, we show superior performance on noisy data. We then apply our approach to study the intracellular signaling of human primary nave CD4+ T-cells, as well as ErbB signaling in trastuzumab resistant breast cancer cells. In both cases, our approach recovers known interactions and points to additional relevant processes. In ErbB signaling, our results predict an important role of negative and positive feedback in controlling the cell cycle progression.